Concepedia

Iris Koopmans

IK

5

Publications

213

Citations

5

H-Index

2016

Active since

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Iris Koopmans is an author at University Medical Center Groningen specializing in medicine, immunology, and radiation oncology.

ORCID

Top concepts

Publications per year

2016–2020

5

Publications

5

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

Iris Koopmans, Djoke Hendriks, Douwe F. Samplonius et al. · OncoImmunology · 2018 · 57 citations · Full text

Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins

Harmen van Andel, Zemin Ren, Iris Koopmans et al. · Proceedings of the National Academy of Sciences · 2016 · 50 citations · Full text

, , +17

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction

Djoke Hendriks, Yuan He, Iris Koopmans et al. · OncoImmunology · 2016 · 46 citations · Full text

, , +18

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation

Mark A.J.M. Hendriks, Emily M. Ploeg, Iris Koopmans et al. · OncoImmunology · 2020 · 32 citations · Full text

Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade

Iris Koopmans, Mark A.J.M. Hendriks, Robert J. van Ginkel et al. · Journal of Investigative Dermatology · 2019 · 28 citations

, , +9

Rows per page

1–5 of 5